OCT President Dmitry Sharov shared his vision on the main pharmaceutical industry trends with daily business newspaper Delovoy Peterburg.
Personalized medicine was named as one of the main development vectors which may bring the market to a completely new level. Its technologies are based on cell and biomolecular methods, and include diagnostic, preventive, treatment, and rehabilitation approaches. Indeed, personalized medicine has become increasingly popular among pharmaceutical startups, including those in Russia. Such promising prospects for genuine market change attract not only local biotech-focused venture funds like Primer Capital, but also foreign investors.
More generally, the synergy of medicine and IT is seen as one of the most important aspects of the industry’s development. Recent IT developments in the clinical research sphere help to avoid mistakes, provide high accuracy of data processing and safe storage of large information arrays. Data MATRIX is one of the providers of these important IT solutions.